NASDAQ:ZY - Nasdaq - US98985X1000 - Common Stock - Currency: USD
NASDAQ:ZY (10/18/2022, 8:22:57 PM)
2.43
+0.04 (+1.67%)
The current stock price of ZY is 2.43 USD. In the past month the price decreased by -6.18%. In the past year, price decreased by -76.75%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
DOW | DOW INC | 23.11 | 27.81B | ||
LYB | LYONDELLBASELL INDU-CL A | 12.02 | 24.94B | ||
WLK | WESTLAKE CORP | 18.69 | 14.12B | ||
CBT | CABOT CORP | 11.63 | 4.58B | ||
OLN | OLIN CORP | 22.96 | 3.11B | ||
MEOH | METHANEX CORP | 11.9 | 2.98B | ||
PCTTU | PURECYCLE TECHNOLOGIES INC | N/A | 2.31B | ||
HWKN | HAWKINS INC | 26.57 | 2.19B | ||
BAK | BRASKEM SA-CLASS A- ADR | N/A | 1.76B | ||
PCT | PURECYCLE TECHNOLOGIES INC | N/A | 1.75B | ||
TROX | TRONOX HOLDINGS PLC | N/A | 1.24B | ||
KRO | KRONOS WORLDWIDE INC | 35.04 | 1.01B |
Zymergen, Inc. engages in the design, development, and commercialization of bio-based products. The company is headquartered in Emeryville, California and currently employs 507 full-time employees. The company went IPO on 2021-04-22. Its platform consists of three key capabilities: its collection of accessible biomolecules; its software and data science technology, and its data-driven microbe optimization processes. Its businesses include advanced materials, which seeks to employ bio-advantaged molecules or microbes to develop and deliver products and is focused on four markets: agriculture, water repellency, advanced polymers, and healthcare; drug discovery business leverages its differentiated access to natural products as a source of diverse chemical matter provided by its unified metagenomics database, and automation business, which offers automation technology to organizations involved in lab operations. Its software and data science platform informs, guides, and records its experiments forming the infrastructure for the learning cycle.
ZYMERGEN INC
5959 Horton Street, Suite 700
Emeryville CALIFORNIA US
Employees: 507
Company Website: https://zymergen.com/
Phone: 14158018073.0
The current stock price of ZY is 2.43 USD. The price increased by 1.67% in the last trading session.
The exchange symbol of ZYMERGEN INC is ZY and it is listed on the Nasdaq exchange.
ZY stock is listed on the Nasdaq exchange.
11 analysts have analysed ZY and the average price target is 2.35 USD. This implies a price decrease of -3.46% is expected in the next year compared to the current price of 2.43. Check the ZYMERGEN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ZYMERGEN INC (ZY) has a market capitalization of 253.58M USD. This makes ZY a Micro Cap stock.
ZYMERGEN INC (ZY) currently has 507 employees.
ZYMERGEN INC (ZY) has a support level at 2.34 and a resistance level at 2.62. Check the full technical report for a detailed analysis of ZY support and resistance levels.
The Revenue of ZYMERGEN INC (ZY) is expected to decline by -21.93% in the next year. Check the estimates tab for more information on the ZY EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ZY does not pay a dividend.
ZYMERGEN INC (ZY) will report earnings on 2022-11-11, after the market close.
ZYMERGEN INC (ZY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.34).
ChartMill assigns a technical rating of 1 / 10 to ZY. When comparing the yearly performance of all stocks, ZY is a bad performer in the overall market: 73.38% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to ZY. ZY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months ZY reported a non-GAAP Earnings per Share(EPS) of -3.34. The EPS increased by 53.02% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -2508.94% | ||
ROA | -77.49% | ||
ROE | N/A | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 44% to ZY. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 33.88% and a revenue growth -21.93% for ZY